首页> 美国卫生研究院文献>Polymers >Engineering Polyzwitterion and Polydopamine Decorated Doxorubicin-Loaded Mesoporous Silica Nanoparticles as a pH-Sensitive Drug Delivery
【2h】

Engineering Polyzwitterion and Polydopamine Decorated Doxorubicin-Loaded Mesoporous Silica Nanoparticles as a pH-Sensitive Drug Delivery

机译:工程聚两性离子和聚多巴胺修饰的阿霉素负载介孔二氧化硅纳米粒子作为pH敏感的药物传递。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Multifunctional drug carriers have great applications in biomedical field. In this study, we introduced both polydopamine (PDA) and zwitterionic polymer of poly(3-(3-methacrylamidopropyl-(dimethyl)-ammonio)propane-1-sulfonate) (PSPP) onto the surface of mesoporous silica nanoparticles (MSNs) to develop a novel nanoparticle (MSNs@PDA-PSPP), which was employed as a new kind of drug carrier for the delivery of doxorubicin (DOX). The PDA coating, as a gatekeeper, could endow the drug carrier with pH-sensitive drug release performance. The outermost PSPP layer would make the drug carrier possess protein resistance performance. The chemical structure and properties were characterized by Fourier transform infrared spectroscopy (FTIR), transmission electron microscopy (TEM), dynamic light scattering (DLS) and thermogravimetric analysis (TGA). MSNs@PDA-PSPP could keep good colloidal stability within 72 h in phosphate buffered saline (PBS) and protein solutions. Meanwhile, MSNs@PDA-PSPP exhibited a high drug loading for DOX. In vitro drug release experiments suggested MSNs-DOX@PDA-PSPP exhibited pH-dependent drug release behaviors. Besides, MSNs@PDA-PSPP had no cytotoxicity to human hepatocellular carcinoma cells (HepG2 cells) even at a concentration of 125 µg/mL. More importantly, cellular uptake and in vitro anticancer activity tests suggested that MSNs-DOX@PDA-PSPP could be taken up by HepG2 cells and DOX could be successfully released and delivered into the cell nuclei. Taken together, MSNs@PDA-PSPP have great potential in the biomedical field.
机译:多功能药物载体在生物医学领域具有广泛的应用。在这项研究中,我们将聚多巴胺(PDA)和聚(3-(3-甲基丙烯酰胺基丙基-(二甲基)-铵)丙烷-1-磺酸盐)(PSPP)的两性离子聚合物引入到介孔二氧化硅纳米颗粒(MSN)的表面,开发出一种新型的纳米粒子(MSNs @ PDA-PSPP),该纳米粒子被用作一种新型的药物载体,用于递送阿霉素(DOX)。 PDA涂层作为看门人可以赋予药物载体以pH敏感的药物释放性能。最外层的PSPP层将使药物载体具有蛋白抗性。化学结构和性质通过傅立叶变换红外光谱(FTIR),透射电子显微镜(TEM),动态光散射(DLS)和热重分析(TGA)进行表征。 MSNs @ PDA-PSPP在磷酸盐缓冲液(PBS)和蛋白质溶液中可在72小时内保持良好的胶体稳定性。同时,MSNs @ PDA-PSPP对DOX表现出很高的载药量。体外药物释放实验表明,MSNs-DOX @ PDA-PSPP表现出pH依赖性药物释放行为。此外,即使浓度为125 µg / mL,MSNs @ PDA-PSPP对人肝癌细胞(HepG2细胞)也没有细胞毒性。更重要的是,细胞摄取和体外抗癌活性测试表明,HepG2细胞可以吸收MSNs-DOX @ PDA-PSPP,而DOX则可以成功释放并传递到细胞核中。综上所述,MSNs @ PDA-PSPP在生物医学领域具有巨大的潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号